Geode Capital Management, LLC Akebia Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,795,095 shares of AKBA stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,795,095
Previous 4,754,464
0.85%
Holding current value
$10.2 Million
Previous $6.28 Million
42.12%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding AKBA
# of Institutions
131Shares Held
61.9MCall Options Held
171KPut Options Held
185K-
Black Rock Inc. New York, NY11.6MShares$24.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$23.2 Million0.0% of portfolio
-
State Street Corp Boston, MA6.3MShares$13.4 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$12.2 Million20.26% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.82MShares$8.14 Million0.01% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $392M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...